Verrica Pharmaceuticals Inc. (VRCA) reported Loss for its second quarter that increased from last year but beat the Street estimates.
The company's earnings totaled -$17.19 million, or -$0.37 per share. This compares with -$10.99 million, or -$0.24 per share, in last year's second quarter.
Excluding items, Verrica Pharmaceuticals Inc. reported adjusted earnings of -$14.44 million or -$0.31 per share for the period.
Analysts on average had expected the company to earn -$0.42 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 177.8% to $0.50 million from $0.18 million last year.
Verrica Pharmaceuticals Inc. earnings at a glance (GAAP) :
-Earnings (Q2): -$17.19 Mln. vs. -$10.99 Mln. last year.
-EPS (Q2): -$0.37 vs. -$0.24 last year.
-Revenue (Q2): $0.50 Mln vs. $0.18 Mln last year.
For comments and feedback: editorial@rttnews.com